Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts

Despite immune checkpoint blockade (ICB) therapy contributed to significant advances in cancer therapy, only a small percentage of patients with colorectal cancer (CRC) respond to it. Identification of these patients will facilitate ICB application in CRC. In this study, we integrated multiple CRC c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hufei, Li, Zhi, Ou, Suwen, Song, Yanni, Luo, Kangjia, Guan, Zilong, Zhao, Lei, Huang, Rui, Yu, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274205/
https://www.ncbi.nlm.nih.gov/pubmed/35836930
http://dx.doi.org/10.3389/fmolb.2022.884839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274205/
https://www.ncbi.nlm.nih.gov/pubmed/35836930
http://dx.doi.org/10.3389/fmolb.2022.884839

Ejemplares similares